- Financial Target Setting and Market Expectations: One Stop Systems (OSS) recently released its financial guidance for fiscal year 2026, projecting revenue growth of 20% to 25%, maintaining a gross margin of approximately 40%, with both EBITDA and adjusted EBITDA expected to turn positive.
- Regulatory warning triggers compliance rectification deadline: Tian Di Hui Foods (Nasdaq: PETZ) recently announced that it has received a regulatory notice from the Nasdaq Exchange, stating that the current composition of its board of directors and audit committee does not meet the independent director ratio requirements under the listing rules.
- New drug approval boosts market confidence: The US Food and Drug Administration (FDA) has officially approved the oral psoriasis treatment jointly developed by Protagonist Therapeutics and Johnson & Johnson. Driven by this news, Protagonist's stock price rose by about 4% in pre-market trading.
- **Key Clinical Data to Be Revealed Soon** Biopharmaceutical company Alumis Inc. announced that the phase III clinical trial data of its lead candidate drug Envudeucitinib for the treatment of moderate-to-severe plaque psoriasis has been selected for the "Late-Breaking Breakthroughs" oral presentation session at the 2026 American Academy of Dermatology (AAD) Annual Meeting.
- **Key Clinical Data to Be Revealed Soon** Biopharmaceutical company Alumis Inc. announced that the phase III clinical trial data of its lead candidate drug Envudeucitinib for the treatment of moderate to severe plaque psoriasis has been selected for the "Late-Breaking Breakthroughs" oral presentation session at the 2026 American Academy of Dermatology (AAD) Annual Meeting.
- Pippin Plunges 85% as Whale Profit Collapses from $7M to Below $1M
- Energy cost shockwave spreads to the industrial gas sector: At a recent industrial gas industry conference hosted by JPMorgan, Air Products & Chemicals (APD) management revealed that persistently high energy prices in Europe are having a significant impact on their large-scale operations in the region.
- Biomerica Receives First Commercial Order for its H. pylori test (Hp Detect) from One of the Largest Clinical Laboratory Chains in Europe
- Kemper (KMPR): Should You Buy, Sell, or Keep After Q4 Results?
- Michael Saylor says bitcoin is not for everyone to own
- The total value locked (TVL) of RWA on BNB Chain surpasses $3 billion, reaching a new all-time high.
- Chipotle's introduction of Cilantro Lime Sauce ignites a viral craze, highlighting America's passion for condiments
- H World Group’s strong Q4 results had been anticipated by the market—what happens next will depend on the company’s 2026 outlook.
- Boyd Group Services Inc. (BGSI) Q4 Results Exceed Expectations
- Boyd Group Services Inc. (BGSI) Q4 Results Surpass Expectations
- Fusemachines’ Interview AI Agent Evaluates Large-Scale Hiring Systems Through Collaboration with Talent Connects
- Trump’s Warsh Nomination Stalls as Market Waits for a Fed Policy Reset It May Never Get
- Zymeworks' Ziihera Approaching a Major Turning Point: Standard Treatment for First-Line GEA Set to Evolve
- CF’s Strategic Green Shift: A Temporary Sector Move That Catches Analysts Off Guard
- Connecticut Suspension: An Examination of Bitcoin Depot's Revenue Decline Through Flow-Based Analysis
- Textron Faces Increased Attention Over Its Conglomerate Discount as Defense Expansion Slows and Specialized Rivals Deliver Stronger Results
- RedotPay’s $1 Billion IPO: An Examination of Expansion and Potential Risks
- Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
- Shipping data shows that Saudi Arabia's Red Sea crude oil loading volume in March is expected to surge to 3.8 million barrels per day.
- Polish Prime Minister says energy cooperation with Russia will not be resumed
- Why April Might Mark the Breakthrough Rivian Shareholders Have Anticipated
- Kasplex EVM ecosystem Meme project SOMPI market cap surpasses 20 million dollars
- US Stocks Move: Palladyne AI surges nearly 11% in pre-market trading
- 2 Undervalued Stocks We’re Tracking and 1 That Falls Short
- Perfect Corp. at $1.95: A Risky Arbitrage Opportunity Amid an Unstable Privatization Proposal
- Oracle AI Smart Assistant: Strengthening Competitive Edge Through Enhanced Operational Integration in an
- Jabil’s Upward Guidance: Achieving a 5.7% Core Margin May Prompt a Valuation Shift
- Is Victory Science & Technology (USSCX) Currently a Top Choice Among Mutual Funds?
- Goodfood's Rapid CFO Exit Amid Leadership Reset: Tactical Transition or Turnaround Warning?
- MSFTON (Microsoft Ondo Tokenized Stock) skyrocketed by 100.9% in 24 hours: Bitget’s listing of Ondo Tokenized Stock boosts trading activity
- METAON (Ondo tokenized Meta stock) fluctuates 101.3% in 24 hours: Bitget's listing of trading pairs drives active trading, price rebounds from $310 to $624
- Rubrik's Sovereign Cloud Strategy: Establishing a Key Position in a Market Growing at 24% CAGR as UK Regulations Accelerate S-Curve Expansion
- Bear Pick for Today: Grid Dynamics (GDYN)
- Bull of the Day: Sanmina (SANM)
改写后：
Top Stock Pick Today: Sanmina (SANM)
- MRT's Ride-Hailing Boom: The Widely Shared Expansion Story Reaches a Key Implementation Stage
- Oracle's New Suite System Could Boost Venue Sales by Making Spending Easier, Faster, and More Transparent
- Oracle's New Suite System Could Boost Venue Sales by Making Spending Easier, Faster, and More Transparent
- AT&T's Agentic AI Framework May Be an Underappreciated Driver for Accelerating the Action Economy
- uCloudlink Group Inc. Sponsored ADR (UCL) Announces Fourth Quarter Loss, Falls Short of Revenue Projections
- Kenya seeks public comment on draft VASP rules covering licensing and stablecoin backing
- Is Putnam Global Technology A (PGTAX) Currently a Top Choice Among Mutual Funds?
- What to Trade Today: Unsteady Technicals and Contradictory Fund Movements Poise Markets for a Turbulent Opening
- How Can Investors Proceed When There Are No 'Cheap' Options?
- PL Ready for Liftoff
- Latest SEC Statement About XRP Excites Ripple CLO: We Always Knew XRP Wasn’t a Security
- Latest SEC Statement About XRP Excites Ripple CLO: We Always Knew XRP Wasn’t a Security
- Crypto Capital Shift: Why Investors Are Watching This $0.04 Altcoin
- Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
- Michael Saylor: STRC Volatility Hits Record Low of 1.5%
- Bitcoin March 18 daily chart alert - Prices trending up
- AMDON (Ondo Tokenized AMD Stock) sees 98.6% volatility in 24 hours: price rebounds from $100 low to $198.62, with no clear time-sensitive catalyst
- Incannex Highlights Strong Balance Sheet with Approximately $75 Million in Cash and No Debt as Company Advances IHL-42X Development
- Trio Petroleum Corp Completes Transformational $19 Million Raise Under ATM Program
- Super League Signs Definitive Agreement to Acquire Misfits Ads Division, Expanding Revenue and Accelerating Path to Positive Adjusted EBITDA
- Bellflower Unified School District Expands Career Exploration with zSpace AR/VR Laptop Lab in Mayfair High School
- Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission
- Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
- Arcutis to Present New Clinical Data in a Late-Breaking Podium Presentation and Scientific Posters at the 2026 American Academy of Dermatology Annual Meeting
- VisionWave Conducts Technology Presentations to Government Officials in Latin America Regarding Homeland Security Drone Applications; SolarDrone Expands Platform with Junko Solar Acquisition
- ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD)
- Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
- Sidoti Events, LLC's March Small-Cap Virtual Conference
- Teads Unveils Global Sports Research Highlighting a Year-Round Attention Opportunity for Brands
- Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting
- ROC to Ring the Nasdaq Closing Bell on March 19, 2026 in Celebration of its Public Listing
- BlackRock and Other Institutions Are Staking ETH — The Supply Squeeze Is Just Getting Started
- InflaRx's AAD Presentation: Can a Partnership Lifeline for Vilobelimab Reverse the Skepticism?
- Chevron’s 6% Yield Hides a Wide Moat That Survives Oil Volatility
- Bitcoin Price Prediction: BTC Consolidates Under $76K – Bull or Bear Ahead?
- G2 Investment Partners Establishes a Fresh Stake in Xometry
- AMZNON (Ondo Amazon Tokenized Stock) 24-hour amplitude at 95.7%: Bitget Listing and AWS Revenue Forecast Upgrade Trigger Movement
- Saylor University Receives Accreditation from the University of Florida, Launches Bitcoin Economics Specialization
- Cryptocurrency plunges sharply, bitcoin drops nearly 2% and falls below $73,000
- TE Connectivity’s Strong Ethical Foundation Drives Sustainable Expansion and Consistent Cash Flow Growth
- S&P 500’s 78% Surge Over Three Years Reflects Ideal Expectations—Be Alert for Potential AI Earnings Letdown
- Experis Addresses the AI "Pilot-to-Production" Challenge Through SoundHound Collaboration—Focuses on Outcome-Driven Earnings Amid Market Expansion
- SHIB Encounters Difficulties in 2026 as Value Drops and Engagement Decreases
- Life360's Durable Competitive Edge and Lucrative Data Cycle Create Strong Buy Opportunity Despite Recent Steep Decline
- Ondas: $140M Agreement Sparks 7% Jump Amid Unprecedented Volume
- Cango's $305M Bitcoin Disposal: The Transaction That Crushed Its Share Price
- USD: Hawkish Fed risk supports Dollar – Societe Generale
- USDJPY remains near its peak levels while market participants look forward to the upcoming FOMC and BoJ interest rate announcements
- Strategy founder says STRC volatility hits record low, Sharpe ratio reaches record high
- Clinical Collaboration and Funding Arrangement: Artelo Biosciences, Inc. (NASDAQ: ARTL) announces the signing of a third-party fully funded clinical research agreement to advance the evaluation of its candidate drug ART27.13 in glaucoma patients.
- Growth dilemma remains unresolved! Disney (DIS.US) appoints new CEO as "infinite" vision faces test
- BURU Jumps 32.7% Overnight—But Volume Fails to Confirm
- Is Now the Right Moment to Invest in the Undervalued SentinelOne Shares?
- Jabil’s (NYSE:JBL) Q1 CY2026: Robust Revenue
- Aluminium: Supply shock supports elevated prices – TD Securities
- Core business remains stable: Global agricultural trading giant Louis Dreyfus Company stated today that despite escalating tensions in the Middle East, its global trade, logistics, and supply chain activities have not been materially affected so far.
- Light’s Legal Tariff Win Could Backfire as Aneel Prepares Appeal
- Brookfield Trades at a 22% Discount to NAV—Is the Market Anticipating a Rare Downturn or Overlooking a Potential Revaluation Trigger?
- Louis Dreyfus Bets on Commodity Cycle Turn as Margins Squeeze Under Prolonged Bear Market
- Bitcoin ETF See Sustained Investor Demand
- Varun Beverages' Acquisition of Crickley Dairy May Indicate Regulatory Approval or Serve as a Caution for South African Expansion
